Bristol-Myers Squibb is another well known pharma company. It’s dividend is generous, but is it secure? in the world. Bristol-Myers Squibb is once again expanding its pipeline. Will it see more growth? Is the dividend secure. Dividend collectors find out here.
AbbVie’s (ABBV) stock has been under pressure for over a year on concerns about Humira’s patent expiration in Europe last year and the loss of protection from competition in the United States beginning in 2023. As a result of these concerns, AbbVie’s stock declined 38% from $123 down to the current price of $76.87. The sharp decline has the stock trading at a bargain valuation.
AbbVie is one of the leading pharma companies in the world. It’s growth however is in question as Humira slowly get biosimilar competition.